Artificial blood substitutes: First steps on the long route to clinical utility

53Citations
Citations of this article
235Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 21st century is challenging for human beings. Increased population growth, population aging, generation of new infectious agents, and natural disasters are some threatening factors for the current state of blood transfusion. However, it seems that science and technology not only could over-come these challenges but also would turn many human dreams to reality in this regard. Scientists believe that one of the future evolutionary innovations could be artificial blood substitutes that might pave the way to a new era in transfusion medicine. In this review, recent status and progresses in artificial blood substitutes, focusing on red blood cells substitutes, are summarized. In addition, steps taken toward the development of artificial blood technology and some of their promises and hurdles will be highlighted. However, it must be noted that artificial blood is still at the preliminary stages of development, and to fulfill this dream, ie, to routinely transfuse artificial blood into human vessels, we still have to strengthen our knowledge and be patient.

Cite

CITATION STYLE

APA

Moradi, S., Jahanian-Najafabadi, A., & Roudkenar, M. H. (2016). Artificial blood substitutes: First steps on the long route to clinical utility. Clinical Medicine Insights: Blood Disorders, 9, 33–41. https://doi.org/10.4137/CMBD.S38461

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free